Monica Mettille, PA
Physician Assistant · Tucson, AZNPI 1538599253
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 261 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 261 payments — averaging $21.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$711
- Sumitomo Pharma America, Inc.$689
- Dendreon Pharmaceuticals LLC$599
- Johnson & Johnson$389
- Teleflex LLC$299
- Myovant Sciences Inc.$234
- plus $3K from 29 others
Across 16 payments — averaging $1356.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bluewind Medical$22K
What the payments were for
- Food & beverage$5,34497%
- Education$1413%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 46 | $711 |
| Sumitomo Pharma America, Inc. | 28 | $689 |
| Dendreon Pharmaceuticals LLC | 26 | $599 |
| Johnson & Johnson | 14 | $389 |
| Teleflex LLC | 10 | $299 |
| Myovant Sciences Inc. | 14 | $234 |
| Urogen Pharma, Inc. | 12 | $210 |
| Sun Pharmaceutical Industries Inc. | 9 | $199 |
| Endo Pharmaceuticals Inc. | 12 | $195 |
| Astellas Pharma US Inc | 8 | $173 |
| Merck | 7 | $152 |
| Coloplast | 8 | $151 |
| Pfizer | 9 | $143 |
| Tolmar Pharmaceuticals, Inc. | 6 | $137 |
| Medtronic | 5 | $125 |
| AbbVie | 6 | $123 |
| Axonics, Inc. | 3 | $113 |
| AstraZeneca | 4 | $97 |
| Tolmar, Inc. | 5 | $96 |
| Calyxo, Inc. | 2 | $89 |
| Urovant Sciences Inc | 5 | $87 |
| Ferring Pharmaceuticals Inc. | 5 | $80 |
| 180 Medical, Inc. | 3 | $54 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $54 |
| Bioprotect Medical, Inc. | 1 | $47 |
| Novartis | 2 | $46 |
| Novo Nordisk | 1 | $28 |
| Amgen | 1 | $27 |
| Koelis Inc. | 1 | $25 |
| Progenics Pharmaceuticals, Inc. | 1 | $24 |
| Blue Earth Diagnostics | 1 | $23 |
| Boston Scientific | 1 | $18 |
| Acerus Pharmaceuticals Corporation | 1 | $16 |
| Accord Healthcare, Inc. | 1 | $15 |
| Olympus America Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift System$132
How this compares
$5,485 in reported general payments places this provider in the 90th percentile of 2,888 physician assistant providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 486 | $493,806 |
| MyrbetriqMirabegron | 317 | $318,728 |
| Mirabegron ErMirabegron | 18 | $13,120 |
| PremarinEstrogens, Conjugated | 20 | $9,044 |
| Estradiol | 117 | $7,205 |
| Trospium Chloride | 72 | $4,339 |
| Methenamine Hippurate | 52 | $4,138 |
| Tamsulosin Hcl | 327 | $3,762 |
| Testosterone | 51 | $3,728 |
| Cephalexin | 216 | $3,372 |
| Finasteride | 200 | $2,627 |
| Solifenacin Succinate | 54 | $2,564 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 95 | $2,057 |
| Tolterodine Tartrate ErTolterodine Tartrate | 16 | $1,962 |
| Potassium Citrate ErPotassium Citrate | 17 | $1,583 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $689 | $493,806486 claims |
| Astellas Pharma US IncMyrbetriq | $173 | $318,728317 claims |
| PfizerPremarin | $143 | $9,04420 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,888 physician assistant providers in Arizona.
Other physician assistant in Tucson
- Nicole StokerTucson$61K
- Robert HoyTucson$41K
- Luis LozanoTucson$31K
- Christy HallTucson$30K
- Jenna HiltonGilbert$637K
- Kara GoodingScottsdale$625K
- Ginna GranrothScottsdale$211K
- Nicole MaderaGlendale$128K
- Candace RyanGlendale$113K
- Christopher BeroScottsdale$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.